Category: Biosimilars
Global Biosimilars
-
Global Peptides Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Peptides Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Peptides Biosimilars ... Read More
-
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Recombinant Non-Glycosylated Proteins Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Biosimilars & Follow-on-Biologics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Biosimilars & Follow-on-Biologics is forecast to a readjusted size of US$ 60550 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential ... Read More
-
Global Retinal Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Retinal Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Retinal Biosimilars ... Read More
-
Global Pen Needles Market - 2024-2031
... period 2024-2031. The global pen needles market witnessed rise in demand as an increasing number of diabetes patients in which insulins are commonly used. Manufacturers introduce various innovative features such as ultra-thin needles, enhanced safety ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Monoclonal antibodies (mAbs) Biosimilars industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Monoclonal antibodies (mAbs) Biosimilars. The report ... Read More
-
Gastrointestinal Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Gastrointestinal Therapeutics market size is poised to register ... Read More
-
Opioid-Induced Constipation Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Opioid-Induced Constipation market size is poised to register ... Read More
-
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030
... market, the Erythropoietin (EPO) Drugs is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.4% during review period. The research report highlights the growth potential of the global ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilars
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Immunology Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption
... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More
-
The 2025-2030 World Outlook for Erythropoietins
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
